pentetic acid has been researched along with Cerebral Ischemia in 35 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of a paramagnetic contrast agent, gadolinium-DTPA (Gd-DTPA), on magnetic resonance (MR) imaging of acute cerebral ischemia was investigated in a feline model of middle cerebral artery occlusion." | 3.67 | Acute experimental cerebral ischemia: MR enhancement using Gd-DTPA. ( Berry, I; Brant-Zawadzki, M; Brasch, RC; Derugin, N; Kucharczyk, W; McNamara, MT; Moore, S; Pereira, B; Weinstein, P, 1986) |
| "Rats underwent a 1-h middle cerebral artery occlusion followed by reperfusion." | 1.43 | Single photon emission computed tomography imaging of cerebral blood flow, blood-brain barrier disruption, and apoptosis time course after focal cerebral ischemia in rats. ( Bucci, C; Dignat-George, F; Filannino, MA; Garrigue, P; Giacomino, L; Guillet, B; Muzio, V; Pisano, P; Sabatier, F, 2016) |
| " Using a single injection of a novel, long half-life intravascular magnetopharmaceutical with a high tissue:blood susceptibility difference (deltachi) to deltaR1 ratio, changes in tissue transverse relaxivity (deltaR2 or deltaR2*) that arise from changes in blood volume were measured, while preserving the ability to measure blood flow using traditional T1-based ASL techniques." | 1.30 | Continuous assessment of perfusion by tagging including volume and water extraction (CAPTIVE): a steady-state contrast agent technique for measuring blood flow, relative blood volume fraction, and the water extraction fraction. ( Bogdanov, AA; Jenkins, BG; Kwong, KK; Marota, JJ; Rosen, BR; Shimizu-Sasamata, M; Weisskoff, RM; Weissleder, R; Zaharchuk, G, 1998) |
| "We report three cases of children with moyamoya disease who revealed prominent leptomeningeal enhancement on postcontrast magnetic resonance (MR) images." | 1.29 | Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood: case report. ( Kuroiwa, T; Ohta, T; Tanaka, H, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (17.14) | 18.7374 |
| 1990's | 27 (77.14) | 18.2507 |
| 2000's | 1 (2.86) | 29.6817 |
| 2010's | 1 (2.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrigue, P | 1 |
| Giacomino, L | 1 |
| Bucci, C | 1 |
| Muzio, V | 1 |
| Filannino, MA | 1 |
| Sabatier, F | 1 |
| Dignat-George, F | 1 |
| Pisano, P | 1 |
| Guillet, B | 1 |
| OJEMANN, RG | 1 |
| ARONOW, SA | 1 |
| SWEET, WH | 1 |
| Barber, PA | 1 |
| Foniok, T | 1 |
| Kirk, D | 1 |
| Buchan, AM | 1 |
| Laurent, S | 1 |
| Boutry, S | 1 |
| Muller, RN | 1 |
| Hoyte, L | 1 |
| Tomanek, B | 1 |
| Tuor, UI | 1 |
| Lanens, D | 1 |
| Spanoghe, M | 1 |
| Van Audekerke, J | 1 |
| Oksendal, A | 1 |
| Van der Linden, A | 1 |
| Dommisse, R | 1 |
| Reith, W | 3 |
| Forsting, M | 3 |
| Vogler, H | 1 |
| Heiland, S | 2 |
| Sartor, K | 4 |
| Dörfler, A | 1 |
| Meyding-Lamadé, U | 1 |
| Langmayr, JJ | 1 |
| Buchberger, W | 1 |
| Birbammer, G | 1 |
| Sumi, M | 1 |
| Takahashi, M | 1 |
| Nagahiro, S | 1 |
| Korogi, Y | 1 |
| Sakamoto, Y | 1 |
| Nishimura, R | 1 |
| Morishita, S | 1 |
| Hamatake, S | 1 |
| Ushio, Y | 1 |
| Jones, RA | 1 |
| Haraldseth, O | 1 |
| Müller, TB | 1 |
| Rinck, PA | 1 |
| Oksendal, AN | 1 |
| Kucharczyk, J | 5 |
| Vexler, ZS | 1 |
| Roberts, TP | 2 |
| Asgari, HS | 3 |
| Mintorovitch, J | 4 |
| Derugin, N | 4 |
| Watson, AD | 1 |
| Moseley, ME | 6 |
| de Crespigny, AJ | 1 |
| Kucharcyzk, J | 1 |
| Maeda, M | 1 |
| Itoh, S | 1 |
| Ide, H | 1 |
| Matsuda, T | 1 |
| Kobayashi, H | 1 |
| Kubota, T | 1 |
| Ishii, Y | 1 |
| Ohta, T | 1 |
| Tanaka, H | 1 |
| Kuroiwa, T | 1 |
| Röther, J | 1 |
| Gückel, F | 2 |
| Neff, W | 1 |
| Schwartz, A | 1 |
| Hennerici, M | 1 |
| Essig, M | 1 |
| von Kummer, R | 1 |
| Egelhof, T | 1 |
| Winter, R | 1 |
| La Noce, A | 1 |
| Miragoli, L | 1 |
| Samuelli, G | 1 |
| Tirone, P | 1 |
| Erb, G | 1 |
| Benner, T | 1 |
| Böck, JC | 1 |
| Goetze, AH | 1 |
| Felix, R | 1 |
| Brix, G | 1 |
| Schreiber, W | 1 |
| Hoffmann, U | 1 |
| Hawighorst, H | 1 |
| Knopp, MV | 1 |
| Zaharchuk, G | 1 |
| Bogdanov, AA | 1 |
| Marota, JJ | 1 |
| Shimizu-Sasamata, M | 1 |
| Weisskoff, RM | 1 |
| Kwong, KK | 1 |
| Jenkins, BG | 1 |
| Weissleder, R | 1 |
| Rosen, BR | 1 |
| Conturo, TE | 1 |
| Barker, PB | 1 |
| Mathews, VP | 1 |
| Monsein, LH | 1 |
| Bryan, RN | 2 |
| Mirowitz, SA | 1 |
| Finelli, DA | 1 |
| Hopkins, AL | 1 |
| Selman, WR | 1 |
| Crumrine, RC | 1 |
| Bhatti, SU | 1 |
| Lust, WD | 1 |
| Häussler, MD | 1 |
| Wallner, B | 1 |
| Bargon, G | 1 |
| Warach, S | 1 |
| Li, W | 1 |
| Ronthal, M | 1 |
| Edelman, RR | 1 |
| Vexler, Z | 1 |
| Rocklage, S | 1 |
| Sevick, R | 1 |
| Wendland, MF | 1 |
| White, DL | 1 |
| Cohen, Y | 1 |
| Kurhanewicz, J | 1 |
| Asgari, H | 1 |
| Norman, D | 2 |
| Rocklage, SM | 1 |
| Quay, SC | 1 |
| Ono, S | 1 |
| Fukunaga, M | 1 |
| Otsuka, N | 1 |
| Nagai, K | 1 |
| Morita, K | 1 |
| Mimura, H | 1 |
| Yanagimoto, S | 1 |
| Tomomitsu, T | 1 |
| Konishi, Y | 1 |
| Yasuda, T | 1 |
| Virapongse, C | 1 |
| Brown, E | 1 |
| Malat, J | 1 |
| Grossman, RI | 1 |
| Hecht-Leavitt, CM | 1 |
| Evans, SM | 1 |
| Lenkinski, RE | 1 |
| Holland, GA | 1 |
| Van Winkle, TJ | 1 |
| McGrath, JT | 1 |
| Curran, WJ | 1 |
| Shetty, A | 1 |
| Joseph, PM | 1 |
| Hashimoto, K | 1 |
| Yamagata, S | 1 |
| Minamikawa, J | 1 |
| Watanabe, Y | 1 |
| Kanesiro, M | 1 |
| Kikuchi, H | 1 |
| McNamara, MT | 1 |
| Brant-Zawadzki, M | 1 |
| Berry, I | 1 |
| Pereira, B | 1 |
| Weinstein, P | 1 |
| Moore, S | 1 |
| Kucharczyk, W | 1 |
| Brasch, RC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of Quantitative Imaging Biomarkers for Evaluating Sarcoma Patients[NCT02579980] | 32 participants (Actual) | Interventional | 2015-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for pentetic acid and Cerebral Ischemia
| Article | Year |
|---|---|
[Methodological approaches to quantitative evaluation of microcirculation in tissues with dynamic magnetic resonance tomography].
Topics: Blood Flow Velocity; Blood Volume; Brain; Brain Ischemia; Capillary Permeability; Cerebrovascular Di | 1997 |
Brain ischemia.
Topics: Aged; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Contrast Media; Gadolinium; | 1989 |
33 other studies available for pentetic acid and Cerebral Ischemia
| Article | Year |
|---|---|
Single photon emission computed tomography imaging of cerebral blood flow, blood-brain barrier disruption, and apoptosis time course after focal cerebral ischemia in rats.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease | 2016 |
SCANNING WITH POSITRON-EMITTING RADIOISOTOPES. OCCLUSIVE CEREBRAL VASCULAR DISEASE.
Topics: Arsenic; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders; Copper; Diagnosis; D | 1964 |
MR molecular imaging of early endothelial activation in focal ischemia.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Contrast Media; Disease Models, Animal; Endothelium, Vascu | 2004 |
Complementary use of T2-weighted and postcontrast T1- and T2*-weighted imaging to distinguish sites of reversible and irreversible brain damage in focal ischemic lesions in the rat brain.
Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Contrast Media; Dy | 1995 |
Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentetate dimeglumine and iron oxide particles.
Topics: Animals; Blood Volume; Brain Ischemia; Capillary Permeability; Cerebral Angiography; Cerebrovascular | 1995 |
MRI monitoring of experimental cerebral ischaemia: comparison of two models.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Cerebral Infarction; Contrast Media; Disease Mo | 1994 |
[Ischemic lesions in the vertebral artery blood flow area as a rare complication of lumbar disk surgery].
Topics: Brain Ischemia; Cerebellum; Contrast Media; Gadolinium DTPA; Humans; Intervertebral Disc Displacemen | 1993 |
Correlation of sequential magnetic resonance imaging of experimental brain ischemia with histologic changes in gerbils.
Topics: Animals; Brain; Brain Ischemia; Contrast Media; Gadolinium DTPA; Gerbillinae; Magnetic Resonance Ima | 1993 |
K-space substitution: a novel dynamic imaging technique.
Topics: Animals; Brain; Brain Ischemia; Contrast Media; Dysprosium; Image Processing, Computer-Assisted; Mag | 1993 |
Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia.
Topics: Acute Disease; Animals; Brain; Brain Ischemia; Cats; Cerebrovascular Circulation; Contrast Media; Ec | 1993 |
Improved sensitivity to magnetic susceptibility contrast.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Dysprosium; Image Enhancement; Image Processin | 1993 |
Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging.
Topics: Acute Disease; Animals; Blood Volume; Brain Ischemia; Cats; Cerebral Cortex; Cerebrovascular Circula | 1993 |
Diffuse leptomeningeal enhancement, "ivy sign," in magnetic resonance images of moyamoya disease in childhood: case report.
Topics: Brain Ischemia; Cerebral Revascularization; Child; Contrast Media; Diagnosis, Differential; Female; | 1995 |
Assessment of regional cerebral blood volume in acute human stroke by use of single-slice dynamic susceptibility contrast-enhanced magnetic resonance imaging.
Topics: Aged; Anticoagulants; Blood Volume; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Cerebrov | 1996 |
Vascular MR contrast enhancement in cerebrovascular disease.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Carotid Artery, Internal; Carotid Stenosis; C | 1996 |
An experimental study on the neurotolerability of gadobenate dimeglumine in a rat model of focal brain ischemia.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Contrast Media; Drug Combinations; Evoked Poten | 1996 |
Dynamic contrast-enhanced T2*-weighted MRI in patients with cerebrovascular disease.
Topics: Acute Disease; Aged; Aged, 80 and over; Brain; Brain Ischemia; Carotid Artery, Internal; Carotid Ste | 1997 |
[Experimental validation of a semi-quantitative single-layer procedure for proton-spin tomographic imaging of regional cerebral perfusion].
Topics: Animals; Brain; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circulation; Contrast Media; Gado | 1997 |
Continuous assessment of perfusion by tagging including volume and water extraction (CAPTIVE): a steady-state contrast agent technique for measuring blood flow, relative blood volume fraction, and the water extraction fraction.
Topics: Animals; Blood Flow Velocity; Blood Volume; Body Water; Brain; Brain Ischemia; Contrast Media; Disea | 1998 |
MR imaging of cerebral perfusion by phase-angle reconstruction of bolus paramagnetic-induced frequency shifts.
Topics: Animals; Brain; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Contrast Media; Dysprosium | 1992 |
Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Ischemia; Brain Neoplasms; Cerebrovascular Dis | 1992 |
Evaluation of experimental early acute cerebral ischemia before the development of edema: use of dynamic, contrast-enhanced and diffusion-weighted MR scanning.
Topics: Acute Disease; Animals; Brain Edema; Brain Ischemia; Contrast Media; Dextrans; Drug Combinations; Fe | 1992 |
[The imaging of regional brain perfusion with dynamic magnetic resonance tomography].
Topics: Brain; Brain Ischemia; Brain Neoplasms; Cerebral Infarction; Cerebrovascular Circulation; Contrast M | 1992 |
Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Cerebral Arteries; Cerebrovascular Circulatio | 1992 |
Comparison of Gd- and Dy-chelates for T2 contrast-enhanced imaging.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Magne | 1991 |
Ultrafast magnetic resonance imaging: diffusion and perfusion.
Topics: Animals; Brain Ischemia; Cats; Cerebral Arteries; Cerebrovascular Disorders; Contrast Media; Diffusi | 1991 |
Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats.
Topics: Acute Disease; Animals; Brain; Brain Ischemia; Cats; Cerebrovascular Circulation; Magnetic Resonance | 1990 |
Imaging of acute stroke.
Topics: Acute Disease; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders; Contrast Media; Diagn | 1990 |
Early detection of perfusion deficits caused by regional cerebral ischemia in cats. T2-weighted magnetic susceptibility MRI using a nonionic dysprosium contrast agent.
Topics: Animals; Brain Ischemia; Cats; Contrast Media; Dysprosium; Magnetic Resonance Imaging; Organometalli | 1990 |
[Single photon emission computed tomography (SPECT) using 99mTc-hexamethyl propyleneamine oxime in patients with ischemic cerebral diseases: comparative study of N-isopropyl-p-[123I]-iodoamphetamine and 99mTc-DTPA SPECT].
Topics: Amphetamines; Brain Ischemia; Female; Humans; Iodine Radioisotopes; Iofetamine; Male; Organotechneti | 1989 |
Experimental radiation injury: combined MR imaging and spectroscopy.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Female; Gadolinium DTPA; Magnetic Resonance Im | 1988 |
[The effect of Gd-DTPA on magnetic resonance imaging: a potential blood-brain barrier indicator].
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Gadolinium; Magnetic Resonance Imaging; Pentetic Acid; | 1988 |
Acute experimental cerebral ischemia: MR enhancement using Gd-DTPA.
Topics: Animals; Brain Ischemia; Cats; Cerebral Cortex; Contrast Media; Gadolinium; Magnetic Resonance Spect | 1986 |